Utility of cooling patches to prevent hand-foot syndrome caused by pegylated liposomal doxorubicin in breast cancer patients

doi:10.12998/wjcc.v9.i33.10075

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 33

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3769)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-10) series.

Item

Count

PDF

206

WORD

112

HTML

2256

Figures (1-1)

175

Tables (1-10)

286

Sum=3035

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

224

Download

510

Sum=734

Nov 26, 2021 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Nov 26, 2021; 9(33): 10075-10087
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10075

Table 5 Comparison of the general self-efficacy scale score between the two groups

GSES score	1^st	2^nd	3^rd	4^th
Control group	19.48 ± 5.88	18.40 ± 5.55	17.52 ± 4.82	17.22 ± 5.16
Cooling group	21.61 ± 6.13	20.67 ± 6.08	19.94 ± 5.81	19.63 ± 6.42
F	0.021	0.479	0.552	1.647
P value	0.078	0.053	0.025	0.041

GSES: General self-efficacy scale.

Citation: Zheng YF, Fu X, Wang XX, Sun XJ, He XD. Utility of cooling patches to prevent hand-foot syndrome caused by pegylated liposomal doxorubicin in breast cancer patients. World J Clin Cases 2021; 9(33): 10075-10087
URL: https://www.wjgnet.com/2307-8960/full/v9/i33/10075.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i33.10075